{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T06:41:37Z","timestamp":1795156897014,"version":"4.10.3"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T00:00:00Z","timestamp":1697068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903408"],"award-info":[{"award-number":["81903408"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Excellent Talents Training Funding Project","award":["2018000020124G136"],"award-info":[{"award-number":["2018000020124G136"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The neuropathological confirmation serves as the gold standard for diagnosing Alzheimer's disease (AD), but it is usually not available to the living individuals. In addition, the gold standard for diagnosing Mild Cognitive Impairment (MCI) remains unclear yet. Neuropsychological testing, such as the Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE) and Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-cog), is commonly used tests in identifying AD and MCI, offering convenience, affordability, non-invasiveness, and accessibility in clinical settings. We aimed to accurately evaluate the discriminative ability of the three tests administrated at the same visit simultaneously in detecting AD and MCI due to AD in the absence of a gold standard.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1289 participants aged over 65 were included from the baseline visits of Alzheimer\u2019s disease Neuroimaging Initiative. Bayesian latent class models, accounting for conditional dependence between MoCA and MMSE, were conducted to assess the diagnostic accuracy of the three tests for detecting AD and MCI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In detecting AD, the ADAS-cog had the highest Youden's Index (0.829), followed by the MoCA(0.813) and MMSE(0.796). The ADAS-cog and MoCA showed similar sensitivity (0.922 vs 0.912) and specificity (0.907 vs 0.901), while the MMSE had lower sensitivity (0.874) and higher specificity (0.922). For MCI detection, the ADAS-cog had the highest Youden's Index (0.704) compared to the MoCA (0.614) and MMSE (0.478). The ADAS-cog exhibited the highest sensitivity, closely followed by the MoCA and MMSE (0.869 vs 0.845 vs 0.757), and the ADAS-cog also had good specificity (0.835 vs 0.769 vs 0.721). The estimated true prevalence of AD among individuals aged over 65 was 20.0%, and the estimated true prevalence of MCI due to AD was 24.8%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings suggest that the ADAS-cog and MoCA are reliable tools for detecting AD and MCI, while the MMSE may be less sensitive in detecting these conditions. A large underdiagnosis of the MCI and Alzheimer\u2019s population still remains in clinical screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-023-01265-6","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T23:28:55Z","timestamp":1697066935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer's disease and mild cognitive impairment: a retrospective analysis of the ADNI database"],"prefix":"10.1186","volume":"28","author":[{"given":"Xiaonan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,12]]},"reference":[{"issue":"4","key":"1265_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/alz.13016","volume":"19","author":"Alzheimer\u2019s Association","year":"2023","unstructured":"Alzheimer\u2019s Association. 2023 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2023;19(4):1598\u2013695. https:\/\/doi.org\/10.1002\/alz.13016.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1265_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM. Alzheimer\u2019s disease. Eur J Neurol. 2018;25(1):59\u201370. https:\/\/doi.org\/10.1111\/ene.13439.","journal-title":"Eur J Neurol"},{"issue":"12","key":"1265_CR3","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1001\/archneur.58.12.1985","volume":"58","author":"RC Petersen","year":"2001","unstructured":"Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1983\u201392. https:\/\/doi.org\/10.1001\/archneur.58.12.1985.","journal-title":"Arch Neurol"},{"key":"1265_CR4","unstructured":"Alzheimer's Disease International, World Alzheimer Report 2022: Life after diagnosis: Navigating treatment, care and support. 2022. https:\/\/www.alzint.org\/u\/World-Alzheimer-Report-2022\/."},{"key":"1265_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-020-01948-3","author":"L Yuan","year":"2021","unstructured":"Lu Y, Liu C, Yu D, et al. Prevalence of mild cognitive impairment in community-dwelling Chinese populations aged over 55 years: a meta-analysis and systematic review. BMC Geriatr. 2021. https:\/\/doi.org\/10.1186\/s12877-020-01948-3.","journal-title":"BMC Geriatr"},{"issue":"6","key":"1265_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, Villain N, Frisoni GB, et al. Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol. 2021;20(6):484\u201396. https:\/\/doi.org\/10.1016\/S1474-4422(21)00066-1.","journal-title":"Lancet Neurol"},{"key":"1265_CR7","doi-asserted-by":"publisher","DOI":"10.1159\/000469658","author":"JA Mat\u00edas-Guiu","year":"2017","unstructured":"Mat\u00edas-Guiu JA, Valles-Salgado M, Rognoni T, et al. Comparative diagnostic accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for screening of Alzheimer disease. Dement Geriatr Cogn Disord. 2017. https:\/\/doi.org\/10.1159\/000469658.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1265_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.7326\/M19-3889","volume":"172","author":"LS Hemmy","year":"2020","unstructured":"Hemmy LS, Linskens EJ, Silverman PC, et al. Brief Cognitive tests for distinguishing clinical Alzheimer-type dementia from mild cognitive impairment or normal cognition in older adults with suspected cognitive impairment: a systematic review. Ann Intern Med. 2020;172:678\u201387. https:\/\/doi.org\/10.7326\/M19-3889.","journal-title":"Ann Intern Med"},{"key":"1265_CR9","doi-asserted-by":"publisher","DOI":"10.1080\/13854046.2018.1454511","author":"N Joana","year":"2018","unstructured":"Joana N, Sandra F, Diana D, Jorge A, Isabel S. Validation study of the Alzheimer\u2019s disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer\u2019s disease. Clin Neuropsychol. 2018. https:\/\/doi.org\/10.1080\/13854046.2018.1454511.","journal-title":"Clin Neuropsychol"},{"issue":"11","key":"1265_CR10","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/gps.5179","volume":"34","author":"H Yang","year":"2019","unstructured":"Yang H, Cheng Z, Li Z, et al. Validation study of the Alzheimer\u2019s disease assessment scale-cognitive subscale for people with mild cognitive impairment and Alzheimer\u2019s disease in Chinese communities. Int J Geriatr Psychiatry. 2019;34(11):1658\u201366. https:\/\/doi.org\/10.1002\/gps.5179.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1265_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6.","journal-title":"J Psychiatr Res"},{"issue":"4","key":"1265_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1265_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/JGP.0b013e3182051ab4","volume":"19","author":"M Ganguli","year":"2011","unstructured":"Ganguli M, Blacker D, Blazer DG, et al. Classification of neurocognitive disorders in DSM-5: a work in progress. Am J Geriatr Psychiatry. 2011;19(3):205\u201310. https:\/\/doi.org\/10.1097\/JGP.0b013e3182051ab4.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1265_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12877-015-0103-3","volume":"15","author":"PT Trzepacz","year":"2015","unstructured":"Trzepacz PT, Hochstetler H, Wang S, Walker B, Saykin AJ. Relationship between the Montreal cognitive assessment and mini-mental state examination for assessment of mild cognitive impairment in older adults. BMC Geriatr. 2015;15:107. https:\/\/doi.org\/10.1186\/s12877-015-0103-3.","journal-title":"BMC Geriatr"},{"issue":"11","key":"1265_CR15","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","volume":"141","author":"WG Rosen","year":"1984","unstructured":"Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer\u2019s disease. Am J Psychiatry. 1984;141(11):1356\u201364. https:\/\/doi.org\/10.1176\/ajp.141.11.1356.","journal-title":"Am J Psychiatry"},{"issue":"7","key":"1265_CR16","first-page":"1","volume":"45","author":"ZN Hani","year":"2016","unstructured":"Hani ZN, Eveline S, Lh LL, Nagaendran K. Psychometric properties of Alzheimer\u2019s disease assessment scale-cognitive subscale for mild cognitive impairment and mild Alzheimer\u2019s disease patients in an Asian context. Ann Acad Med Singapore. 2016;45(7):1\u201311.","journal-title":"Ann Acad Med Singapore"},{"issue":"4","key":"1265_CR17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/1533317513488910","volume":"28","author":"JE Gaugler","year":"2013","unstructured":"Gaugler JE, Kane RL, Johnston JA, Sarsour K. Sensitivity and specificity of diagnostic accuracy in Alzheimer\u2019s disease: a synthesis of existing evidence. Am J Alzheimers Dis Other Demen. 2013;28(4):337\u201347. https:\/\/doi.org\/10.1177\/1533317513488910.","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"10","key":"1265_CR18","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jalz.2014.12.001","volume":"11","author":"A Prestia","year":"2015","unstructured":"Prestia A, Caroli A, Wade SK, et al. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. Alzheimers Dement. 2015;11(10):1191\u2013201. https:\/\/doi.org\/10.1016\/j.jalz.2014.12.001.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1265_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/alzrt40","volume":"2","author":"K Rockwood","year":"2010","unstructured":"Rockwood K. Con: Can biomarkers be gold standards in Alzheimer\u2019s disease? Alzheimers Res Ther. 2010;2(3):16. https:\/\/doi.org\/10.1186\/alzrt40.","journal-title":"Alzheimers Res Ther"},{"issue":"10","key":"1265_CR20","doi-asserted-by":"publisher","first-page":"e0223832","DOI":"10.1371\/journal.pone.0223832","volume":"14","author":"CM Umemneku Chikere","year":"2019","unstructured":"Umemneku Chikere CM, Wilson K, Graziadio S, Vale L, Allen AJ. Diagnostic test evaluation methodology: a systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard\u2014an update. PLoS ONE. 2019;14(10):e0223832. https:\/\/doi.org\/10.1371\/journal.pone.0223832.","journal-title":"PLoS ONE"},{"key":"1265_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.0006-341X.2001.00158.x","volume":"57","author":"N Dendukuri","year":"2001","unstructured":"Dendukuri N. Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics. 2001;57:158\u201367. https:\/\/doi.org\/10.1111\/j.0006-341X.2001.00158.x.","journal-title":"Biometrics"},{"issue":"3","key":"1265_CR22","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1541-0420.2009.01330.x","volume":"66","author":"G Jones","year":"2010","unstructured":"Jones G, Johnson WO, Hanson TE, Christensen R. Identifiability of models for multiple diagnostic testing in the absence of a gold standard. Biometrics. 2010;66(3):855\u201363. https:\/\/doi.org\/10.1111\/j.1541-0420.2009.01330.x.","journal-title":"Biometrics"},{"issue":"1","key":"1265_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3233\/JAD-215394","volume":"87","author":"X Wang","year":"2022","unstructured":"Wang X, Li F, Gao Q, et al. Evaluation of the accuracy of cognitive screening tests in detecting dementia associated with Alzheimer\u2019s disease: a hierarchical Bayesian latent class meta-analysis. J Alzheimers Dis. 2022;87(1):285\u2013304. https:\/\/doi.org\/10.3233\/JAD-215394.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1265_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.14283\/jpad.2022.70","volume":"9","author":"X Wang","year":"2022","unstructured":"Wang X, Li F, Zhu H, Jiang Z, Niu G, Gao Q. A Hierarchical Bayesian latent class model for the diagnostic performance of mini-mental state examination and Montreal cognitive assessment in screening mild cognitive impairment due to Alzheimer\u2019s disease. J Prev Alzheimers Dis. 2022;9(4):589\u2013600. https:\/\/doi.org\/10.14283\/jpad.2022.70.","journal-title":"J Prev Alzheimers Dis"},{"key":"1265_CR25","doi-asserted-by":"publisher","DOI":"10.2174\/1567205019666220404104854","author":"SH Park","year":"2022","unstructured":"Park SH, Han K. Is the Alzheimer\u2019s disease assessment scale-cognitive subscale useful in screening for mild cognitive impairment and Alzheimer\u2019s disease? A systematic review. Curr Alzheimer Res. 2022. https:\/\/doi.org\/10.2174\/1567205019666220404104854.","journal-title":"Curr Alzheimer Res"},{"issue":"1\u20132","key":"1265_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/s0167-5877(00)00117-3","volume":"45","author":"C En\u00f8e","year":"2000","unstructured":"En\u00f8e C, Georgiadis MP, Johnson WO. Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown. Prev Vet Med. 2000;45(1\u20132):61\u201381. https:\/\/doi.org\/10.1016\/s0167-5877(00)00117-3.","journal-title":"Prev Vet Med"},{"key":"1265_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2017.01.013","author":"C Delgado","year":"2019","unstructured":"Delgado C, Araneda A, Behrens MI. Validation of the Spanish-language version of the Montreal cognitive assessment test in adults older than 60 years. Neurologia (Barcelona, Spain). 2019. https:\/\/doi.org\/10.1016\/j.nrl.2017.01.013.","journal-title":"Neurologia (Barcelona, Spain)"},{"issue":"6","key":"1265_CR28","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10072-018-3319-0","volume":"39","author":"X Li","year":"2018","unstructured":"Li X, Jia S, Zhou Z, et al. The role of the Montreal Cognitive Assessment (MoCA) and its memory tasks for detecting mild cognitive impairment. Neurol Sci. 2018;39(6):1029\u201334. https:\/\/doi.org\/10.1007\/s10072-018-3319-0.","journal-title":"Neurol Sci"},{"key":"1265_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcp.2017.05.003","author":"SG Aguilar-Navarro","year":"2018","unstructured":"Aguilar-Navarro SG, Mimenza-Alvarado AJ, Palacios-Garc\u00eda AA, et al. Validity and reliability of the spanish version of the Montreal Cognitive Assessment (MoCA) for the detection of cognitive impairment in Mexico. Revista colombiana de psiquiatria. 2018. https:\/\/doi.org\/10.1016\/j.rcp.2017.05.003.","journal-title":"Revista colombiana de psiquiatria"},{"issue":"5","key":"1265_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.12740\/PP\/45368","volume":"50","author":"N Ciesielska","year":"2016","unstructured":"Ciesielska N, Soko\u0142owski R, Mazur E, et al. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis Psychiatr Pol. 2016;50(5):1039\u201352. https:\/\/doi.org\/10.12740\/PP\/45368.","journal-title":"Meta-analysis. Psychiatr Pol"},{"issue":"5","key":"1265_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jalz.2012.10.001","volume":"9","author":"DR Roalf","year":"2013","unstructured":"Roalf DR, Moberg PJ, Xie SX, et al. Comparative accuracies of two common screening instruments for classification of Alzheimer\u2019s disease, mild cognitive impairment, and healthy aging. Alzheimers Dement. 2013;9(5):529\u201337. https:\/\/doi.org\/10.1016\/j.jalz.2012.10.001.","journal-title":"Alzheimers Dement"},{"issue":"4\u20136","key":"1265_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1159\/000501308","volume":"47","author":"TCC Pinto","year":"2019","unstructured":"Pinto TCC, Machado L, Costa MLG, et al. Accuracy and psychometric properties of the Brazilian version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment and Alzheimer\u2019s disease in the initial stages in the elderly. Dement Geriatr Cogn Disord. 2019;47(4\u20136):366\u201374. https:\/\/doi.org\/10.1159\/000501308.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"1265_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/01.wad.0000201846.22213.76","volume":"20","author":"G Pyo","year":"2006","unstructured":"Pyo G, Elble RJ, Ala T, Markwell SJ. The characteristics of patients with uncertain mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale. Alzheimer Dis Assoc Disord. 2006;20(1):16\u201322. https:\/\/doi.org\/10.1097\/01.wad.0000201846.22213.76.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1265_CR34","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170222","author":"SB Jemaa","year":"2017","unstructured":"Jemaa SB, Romdhane NA, Bahri-Mrabet A, et al. An Arabic version of the cognitive subscale of the Alzheimer\u2019s disease assessment scale (ADAS-Cog): reliability, validity, and normative data. J Alzheimer\u2019s Dis. 2017. https:\/\/doi.org\/10.3233\/JAD-170222.","journal-title":"J Alzheimer's Dis"},{"issue":"3","key":"1265_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/WAD.0000000000000403","volume":"34","author":"DKL Sleutjes","year":"2020","unstructured":"Sleutjes DKL, Harmsen IJ, van Bergen FS, et al. Validity of the Mini-Mental state examination-2 in diagnosing mild cognitive impairment and dementia in patients visiting an outpatient clinic in the Netherlands. Alzheimer Dis Assoc Disord. 2020;34(3):278\u201381. https:\/\/doi.org\/10.1097\/WAD.0000000000000403.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"12","key":"1265_CR36","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jagp.2018.09.009","volume":"26","author":"EA Pugh","year":"2018","unstructured":"Pugh EA, Kemp EC, van Dyck CH, Mecca AP, Sharp ES. Effects of normative adjustments to the Montreal cognitive assessment. Am J Geriatr Psychiatry. 2018;26(12):1258\u201367. https:\/\/doi.org\/10.1016\/j.jagp.2018.09.009.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1265_CR37","doi-asserted-by":"publisher","DOI":"10.1159\/000368827","author":"NT Pin","year":"2015","unstructured":"Pin NT, Lei F, Shiong LW, et al. Montreal Cognitive Assessment for screening mild cognitive impairment: variations in test performance and scores by education in Singapore. Dement Geriatr Cogn Disord. 2015. https:\/\/doi.org\/10.1159\/000368827.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"1265_CR38","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/jad-141278","volume":"43","author":"J-P Tan","year":"2015","unstructured":"Tan J-P, Li N, Gao J, et al. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal cognitive assessment among elderly and oldest-Old Chinese population. J Alzheimers Dis. 2015;43(4):1403\u201312. https:\/\/doi.org\/10.3233\/jad-141278.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1265_CR39","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/13607863.2021.1875192","volume":"26","author":"M Lakshminarayanan","year":"2022","unstructured":"Lakshminarayanan M, Vaitheswaran S, Srinivasan N, et al. Cultural adaptation of Alzheimer\u2019s disease assessment scale-cognitive subscale for use in India and validation of the Tamil version for South Indian population. Aging Ment Health. 2022;26(2):423\u201330. https:\/\/doi.org\/10.1080\/13607863.2021.1875192.","journal-title":"Aging Ment Health"},{"key":"1265_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13820","author":"J Parunyou","year":"2015","unstructured":"Parunyou J, Sookjaroen T, Solaphat H, et al. The Montreal cognitive assessment-basic: a screening tool for mild cognitive impairment in illiterate and low-educated elderly adults. J Am Geriatr Soc. 2015. https:\/\/doi.org\/10.1111\/jgs.13820.","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"1265_CR41","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1037\/pas0000271","volume":"28","author":"D Mellor","year":"2016","unstructured":"Mellor D, Lewis M, McCabe M, et al. Determining appropriate screening tools and cut-points for cognitive impairment in an elderly Chinese sample. Psychol Assess. 2016;28(11):1345\u201353. https:\/\/doi.org\/10.1037\/pas0000271.","journal-title":"Psychol Assess"},{"key":"1265_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.prevetmed.2019.01.010","volume":"167","author":"WO Johnson","year":"2019","unstructured":"Johnson WO, Jones G, Gardner IA. Gold standards are out and Bayes is in: implementing the cure for imperfect reference tests in diagnostic accuracy studies. Prev Vet Med. 2019;167:113\u201327. https:\/\/doi.org\/10.1016\/j.prevetmed.2019.01.010.","journal-title":"Prev Vet Med"},{"issue":"2","key":"1265_CR43","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/biom.12583","volume":"73","author":"L Garcia Barrado","year":"2017","unstructured":"Garcia Barrado L, Coart E, Burzykowski T. Estimation of diagnostic accuracy of a combination of continuous biomarkers allowing for conditional dependence between the biomarkers and the imperfect reference-test. Biometrics. 2017;73(2):646\u201355. https:\/\/doi.org\/10.1111\/biom.12583.","journal-title":"Biometrics"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01265-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01265-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01265-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:19:37Z","timestamp":1700623177000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01265-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,12]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1265"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01265-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,12]]},"assertion":[{"value":"9 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical standards Data involved in the study came from the publicly open Alzheimer\u2019s disease neuroimaging initiative (ADNI) database. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the Helsinki Declaration of 1975. The ADNI was approved by medical ethics committees of all participating institutions and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"427"}}